Details for 2015852340
Up to date per 01.04.2026
Actions
Details for 2015852340
Deleted
European Patent
30.08.2017 A
09.12.2020 B1
20.10.2014
US
201462066280 P
07.01.2015
US
201562100844 P
A61K 31/55 20060101AFI20200918BHEP
Owner
Oyster Point Pharma, Inc.202 Carnegie Center, Suite 109 Princeton, New Jersey 08540US
Representative
No representatives present
Inventor
ACKERMANN, Douglas Michael, Jr.341 Crestmont Drive San Francisco, California 94131US
LOUDIN, James203 Kilts Drive Houston, Texas 77024US
MANDELL, Kenneth J.147 Lowell Street Arlington, Massachusetts 02474US